Cleared Traditional

CO2 Mainstream Sensor (K221118) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221118 · Draegerwerk AG & CO Kgaa · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
352d
Days
Class 2
Risk

K221118 is an FDA 510(k) clearance for the CO2 Mainstream Sensor. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Draegerwerk AG & CO Kgaa (Luebeck, DE). The FDA issued a Cleared decision on April 5, 2023 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Draegerwerk AG & CO Kgaa devices

Submission Details

510(k) Number K221118 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2022
Decision Date April 05, 2023
Days to Decision 352 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
212d slower than avg
Panel avg: 140d · This submission: 352d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 67
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K221118.
MicroTrend System
K212425 · Exostat Medical, Inc. · Nov 2024
Oxy2Pro
K222511 · Southmedic, Inc. · Nov 2023
Endure ETCO2/02 Nasal Cannula
K213767 · Endure Industries, Inc. · Sep 2023
XChange Device, XChange System
K210112 · Pneuma Therapeutics, Inc. · Jan 2023
Endoscopy Oxygen Mask
K220533 · Engineered Medical Systems, Inc. · Nov 2022
Microstream CO2 NanoPod
K213911 · Covidien, LLC · Jul 2022